- Home
- AMST vs HOTH Comparison
AMST vs HOTH Comparison
Compare AMST & HOTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMST
- HOTH
- Stock Information
- Founded
- AMST 2017
- HOTH 2017
- Country
- AMST United States
- HOTH United States
- Employees
- AMST N/A
- HOTH N/A
- Industry
- AMST Computer Software: Prepackaged Software
- HOTH Biotechnology: Pharmaceutical Preparations
- Sector
- AMST Technology
- HOTH Health Care
- Exchange
- AMST Nasdaq
- HOTH Nasdaq
- Market Cap
- AMST 9.5M
- HOTH 15.6M
- IPO Year
- AMST 2020
- HOTH 2019
- Fundamental
- Price
- AMST $3.21
- HOTH $1.34
- Analyst Decision
- AMST
- HOTH Strong Buy
- Analyst Count
- AMST 0
- HOTH 3
- Target Price
- AMST N/A
- HOTH $4.00
- AVG Volume (30 Days)
- AMST 105.5K
- HOTH 649.5K
- Earning Date
- AMST 05-15-2025
- HOTH 05-12-2025
- Dividend Yield
- AMST N/A
- HOTH N/A
- EPS Growth
- AMST N/A
- HOTH N/A
- EPS
- AMST N/A
- HOTH N/A
- Revenue
- AMST $82,544.00
- HOTH N/A
- Revenue This Year
- AMST N/A
- HOTH N/A
- Revenue Next Year
- AMST N/A
- HOTH N/A
- P/E Ratio
- AMST N/A
- HOTH N/A
- Revenue Growth
- AMST N/A
- HOTH N/A
- 52 Week Low
- AMST $2.00
- HOTH $0.58
- 52 Week High
- AMST $6.27
- HOTH $3.80
- Technical
- Relative Strength Index (RSI)
- AMST 57.34
- HOTH 55.54
- Support Level
- AMST $3.13
- HOTH $1.17
- Resistance Level
- AMST $3.32
- HOTH $1.57
- Average True Range (ATR)
- AMST 0.25
- HOTH 0.09
- MACD
- AMST 0.03
- HOTH 0.00
- Stochastic Oscillator
- AMST 55.41
- HOTH 50.00
About AMST Amesite Inc.
Amesite Inc is an artificial intelligence-driven platform and course designer that rapidly provides customized, high-performance and scalable online products for schools and businesses. The company helps educational institutions and businesses improve learning as their technology partner, delivering a disruptive technology driven by AI and offers a constellation of services that help partners implement new programs, and improve existing ones. Its customers are Enterprises, universities, and K-12 schools.
About HOTH Hoth Therapeutics Inc.
Hoth Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing new-generation therapies for unmet medical needs. It is focused on developing a topical formulation for treating side effects from drugs used for the treatment of cancer (HT-001); a treatment for mast-cell derived cancers and anaphylaxis (HT-KIT); and a treatment and/or prevention for Alzheimer's or other neuroinflammatory diseases (HT-ALZ). The company also has assets being developed for atopic dermatitis (also known as eczema) (BioLexa); a treatment for asthma and allergies using inhalational administration (HT-004); and an obesity treatment, and obesity-related diseases and conditions (HT-VA).